Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.78M Buy
37,231
+448
+1% +$52.4K 0.16% 64
2026
Q1
$4.42M Buy
36,783
+2,302
+7% +$266K 0.17% 66
2025
Q4
$3.63M Buy
34,481
+239
+0.7% +$22.4K 0.14% 71
2025
Q3
$2.87M Buy
34,242
+956
+3% +$78.7K 0.11% 71
2025
Q2
$2.63M Buy
33,286
+1,419
+4% +$113K 0.11% 67
2025
Q1
$2.84M Buy
31,867
+1,204
+4% +$112K 0.13% 64
2024
Q4
$3.02M Sell
30,663
-37
-0.1% -$3.81K 0.14% 66
2024
Q3
$3.49M Buy
30,700
+46
+0.2% +$5.46K 0.15% 62
2024
Q2
$3.79M Sell
30,654
-196
-0.6% -$25.2K 0.18% 61
2024
Q1
$4.07M Buy
30,850
+1,040
+3% +$128K 0.2% 58
2023
Q4
$3.25M Sell
29,810
-270
-0.9% -$28K 0.18% 61
2023
Q3
$3.1M Buy
30,080
+35
+0.1% +$3.77K 0.18% 59
2023
Q2
$3.47M Buy
30,045
+255
+0.9% +$29K 0.2% 59
2023
Q1
$3.17M Buy
29,790
+5
+0% +$540 0.18% 59
2022
Q4
$3.3M Buy
29,785
+259
+0.9% +$26.5K 0.19% 56
2022
Q3
$2.54M Buy
29,526
+499
+2% +$44.5K 0.17% 58
2022
Q2
$2.65M Buy
29,027
+31
+0.1% +$2.75K 0.16% 59
2022
Q1
$2.38M Buy
28,996
+567
+2% +$44.7K 0.14% 66
2021
Q4
$2.18M Buy
28,429
+90
+0.3% +$7.17K 0.13% 65
2021
Q3
$2.13M Buy
28,339
+270
+1% +$20.5K 0.14% 65
2021
Q2
$2.18M Sell
28,069
-1,241
-4% -$92.3K 0.15% 64
2021
Q1
$2.16M Buy
29,310
+1,605
+6% +$118K 0.16% 56
2020
Q4
$2.16M Sell
27,705
-98
-0.4% -$7.5K 0.17% 52
2020
Q3
$2.2M Sell
27,803
-1,578
-5% -$124K 0.19% 45
2020
Q2
$2.17M Buy
29,381
+7,556
+35% +$569K 0.2% 42
2020
Q1
$1.6M Buy
21,825
+9,751
+81% +$766K 0.17% 46
2019
Q4
$1.05M Buy
12,074
+1,228
+11% +$101K 0.1% 55
2019
Q3
$871K Sell
10,846
-120
-1% -$9.62K 0.09% 59
2019
Q2
$877K Buy
10,966
+229
+2% +$17.5K 0.09% 58
2019
Q1
$852K Buy
10,737
+543
+5% +$40.6K 0.09% 55
2018
Q4
$743K Buy
10,194
+108
+1% +$7.62K 0.09% 54
2018
Q3
$683 Buy
10,086
+56
+0.6% +$3.57K 0.07% 61
2018
Q2
$581K Buy
10,030
+2,338
+30% +$132K 0.07% 63
2018
Q1
$400K Buy
7,692
+775
+11% +$41.9K 0.05% 78
2017
Q4
$371K Buy
6,917
+546
+9% +$30.3K 0.06% 78
2017
Q3
$389K Hold
6,371
0.07% 67
2017
Q2
$390K Sell
6,371
-1,171
-16% -$71.3K 0.07% 87
2017
Q1
$458K Sell
7,542
-666
-8% -$40.4K 0.09% 57
2016
Q4
$461K Sell
8,208
-159
-2% -$9.3K 0.09% 60
2016
Q3
$498K Buy
8,367
+872
+12% +$51K 0.1% 62
2016
Q2
$412K Sell
7,495
-11,300
-60% -$601K 0.08% 58
2016
Q1
$949K Sell
18,795
-196
-1% -$9.6K 0.16% 49
2015
Q4
$957K Buy
18,991
+559
+3% +$28.2K 0.17% 49
2015
Q3
$869K Buy
18,432
+524
+3% +$27.8K 0.17% 47
2015
Q2
$973K Sell
17,908
-1,090
-6% -$61.1K 0.18% 48
2015
Q1
$1.04K Hold
18,998
0.19% 47
2014
Q4
$1.03M Hold
18,998
0.2% 45
2014
Q3
$1.07M Hold
18,998
0.22% 45
2014
Q2
$1.05M Sell
18,998
-171
-0.9% -$9.33K 0.22% 48
2014
Q1
$1.04M Sell
19,169
-5,812
-23% -$301K 0.24% 44
2013
Q4
$1.19M Buy
24,981
+905
+4% +$41.4K 0.27% 44
2013
Q3
$1.09M Sell
24,076
-358
-1% -$16.3K 0.27% 45
2013
Q2
$1.08M Buy
+24,434
New +$1.09M 0.28% 43

Other funds holding MRK

Welch Group's MRK Position: Q2 2026 in Review

Welch Group increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $52.4K and bringing the position to 37,231 shares worth $4.78M. The position accounts for 0.16% of the portfolio, ranked #64.

Welch Group first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,583 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Welch Group held 37,231 shares of Merck worth $4.78M as of Q2 2026.
  • Welch Group bought 448 Merck shares in Q2 2026, an estimated $52.4K.
  • Merck made up 0.16% of Welch Group's portfolio in Q2 2026, its #64 holding.
  • Welch Group first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 1,583 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.